Profile: Xiaoxia Chen has led the early discovery and preclinical research for several metabolic and tumor-targeted peptide drugs. She is not only proficient in high-throughput screening of peptide libraries but also skilled in utilizing AI-assisted computational biology for de novo peptide sequence design. Currently, Nws tab tom coj ib pab neeg tshwj xeeb rau kev tshawb fawb tob thiab kev tsim kho tshiab ntawm cov tshuaj ua haujlwm ntau yam tshiab (xws li ob leeg- lossis peb hom hom peptides txo rog) thiab cov peptides kho cov ntaub so ntswg muaj zog heev.